Search results
10x Genomics, Inc. is an American biotechnology company that designs and manufactures gene sequencing technology used in scientific research. It was founded in 2012 by Serge Saxonov, Ben Hindson, and Kevin Ness.
Feb 7, 2024 · PLEASANTON, Calif., Feb. 7, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today the launch of GEM-X, the next generation of the...
Feb 5, 2024 · 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today a series of new products and technology demonstrations that will be presented at the 2024 Advances...
Jan 8, 2024 · 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced preliminary, unaudited select results for the fourth quarter and full year ended December 31, 2023.
Feb 5, 2024 · PLEASANTON, Calif., Feb. 5, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG ), a leader in single cell and spatial biology, announced today a series of new products and technology...
Aug 7, 2023 · Aug 7, 2023,01:54pm EDT. Share to Facebook. Share to Twitter. Share to Linkedin. 10X Genomics uses technology such as AI to explore and advance spatial biology. Digital Creative Associates....
14 hours ago · 10X Genomics: 10X Genomics will provide two reactions of GEM-x 3’ or 5’ gene expression and Flex reagents at no cost. This can be combined with the no-cost sequencing reagents. Illumina: Illumina will provide reagents for a single 10B lane (1.25B reads) of 2x150bp sequencing at no cost. Key Dates. Application open date.
